Annals of Indian Academy of Neurology
Scope & Guideline
Advancing Neurological Insights for a Healthier Tomorrow
Introduction
Aims and Scopes
- Neurological Disorders Research:
The journal covers a comprehensive range of neurological disorders, including but not limited to Parkinson's disease, stroke, epilepsy, and neurodegenerative diseases. It emphasizes both clinical and experimental research to enhance understanding and treatment. - Clinical Trials and Interventions:
A significant portion of the journal's publications focuses on clinical trials assessing the efficacy and safety of various therapeutic interventions, including pharmacological treatments, surgical procedures, and alternative therapies. - Epidemiology and Public Health:
The journal addresses the epidemiological aspects of neurological disorders, particularly in the Indian context, exploring risk factors, prevalence, and the impact of socio-economic factors on neurological health. - Neurogenetics and Biomarkers:
There is a growing emphasis on genetic studies and the identification of biomarkers that can aid in the early diagnosis and treatment of neurological conditions, reflecting the trend towards precision medicine in neurology. - Innovative Diagnostic Techniques:
The journal promotes the use of advanced diagnostic methodologies, including neuroimaging techniques and electrophysiological assessments, to improve diagnostic accuracy and patient outcomes. - Neurorehabilitation and Quality of Life:
Research on rehabilitation strategies and their effects on quality of life for patients with neurological disorders is a key focus, highlighting the importance of comprehensive care beyond pharmacological treatment.
Trending and Emerging
- COVID-19 Neurological Complications:
A significant increase in research addressing the neurological effects of COVID-19 has been observed, including studies on post-viral syndromes and neurological manifestations associated with the infection. - Telemedicine in Neurology:
The pandemic has accelerated the adoption of telemedicine in neurology, leading to a surge in research on its effectiveness, challenges, and potential for enhancing patient care. - Neuroimmunology and Autoimmune Disorders:
There is a growing emphasis on neuroimmunological disorders, particularly autoimmune encephalitis and related conditions, reflecting increased awareness and advancements in diagnostic techniques. - Neurodegenerative Diseases and Biomarker Research:
Research on neurodegenerative diseases, particularly the identification of new biomarkers for early diagnosis and monitoring of conditions like Alzheimer's and Parkinson's diseases, has gained momentum. - Mental Health and Neurology:
An emerging focus on the intersection of mental health and neurological disorders is evident, with studies exploring the psychological impact of neurological diseases and the importance of integrated care. - Genetic Studies and Precision Medicine:
The trend towards precision medicine is evident through an increase in genetic research aimed at understanding the hereditary aspects of neurological disorders and tailoring treatments accordingly.
Declining or Waning
- Traditional Neurological Assessments:
There has been a noticeable decline in publications focusing solely on traditional neurological assessment techniques, as newer and more comprehensive diagnostic methods gain favor. - Basic Research in Neurobiology:
Research dedicated to basic neurobiological mechanisms has decreased, possibly overshadowed by clinical and translational studies that emphasize direct patient outcomes. - Case Reports:
The frequency of unique case reports has diminished, as the journal increasingly prioritizes larger studies and comprehensive reviews that provide broader insights into neurological conditions. - Historical Perspectives on Neurology:
Papers focusing on the historical aspects of neurology or retrospective analyses of long-standing practices have become less common, indicating a shift towards contemporary issues and advancements. - Pharmacological Studies on Older Medications:
Research centered on older or traditional pharmacological treatments has waned, as the focus shifts towards newer therapies and innovative treatment modalities.
Similar Journals
PEDIATRIC NEUROLOGY
Empowering Healthcare through Cutting-edge Neurological StudiesPediatric Neurology, a prestigious journal published by Elsevier Science Inc, is a leading resource in the field of child neurology and developmental neurosciences. With an impressive impact factor and categorization in the Q1 and Q2 quartiles across several relevant fields, including Pediatrics, Neurology, and Developmental Neuroscience, this journal is essential for researchers and healthcare professionals focused on pediatric neurological disorders. Since its inception in 1985, it has provided a platform for high-quality research, clinical studies, and reviews that drive advancements in diagnosis, treatment, and understanding of neurological conditions in children. Although the journal does not currently offer open access, it maintains a robust reputation in the academic community, bolstered by its prominent ranking in Scopus metrics. By engaging with the latest findings published in Pediatric Neurology, readers will gain vital insights that contribute to improving pediatric healthcare outcomes in neurology and neuroscience.
JOURNAL OF NEUROLOGY
Exploring the depths of clinical and fundamental neurology.The Journal of Neurology, published by Springer Heidelberg, stands as a distinguished platform within the realm of neurology, encompassing both fundamental and clinical aspects of the field. With an impressive impact factor and notable rankings—43rd out of 400 in clinical neurology and 22nd out of 192 in neuroscience—this journal consistently showcases high-quality research and groundbreaking studies. Established in 1974, it has evolved over nearly half a century to adapt to the latest advancements, maintaining its Q1 quartile ranking for both neurology and clinical neurology in 2023. With an extensive scope that includes original research, reviews, and case reports, the journal fosters knowledge dissemination and engages a global audience of researchers, clinicians, and students. Although it does not currently offer open access options, its rigorous peer-reviewed publication process ensures that only the most impactful studies contribute to the understanding and advancement of neurological sciences.
Ideggyogyaszati Szemle-Clinical Neuroscience
Elevating Understanding in Clinical NeurologyIdeggyogyaszati Szemle-Clinical Neuroscience, an esteemed publication under the auspices of LITERATURA MEDICA, serves as a pivotal platform in the field of neurology and clinical neuroscience. Established in Hungary, this journal has been committed to advancing the understanding of neurological disorders and treatments since its inception. With its ISSN 0019-1442 and E-ISSN 2498-6208, it provides a unique local perspective alongside valuable contributions to the global discourse in neuroscience. Despite earning a Q4 quartile ranking in both Neurology and Clinical Neurology, the journal remains dedicated to publishing high-quality research that contributes to the scientific community's collective knowledge. Its coverage spans significant converged years from 1954 to 1985 and now continues through 2024, reflecting a rich historical foundation. Recognizing the importance of open access, the journal strives to enhance accessibility, albeit currently lacking a formal open-access model. Researchers, professionals, and students in the field will find in Ideggyogyaszati Szemle a resource vital for keeping abreast of emerging trends and findings in neurological science.
NEUROLOGICAL SCIENCES
Elevating knowledge in neurological sciences for a healthier tomorrow.NEUROLOGICAL SCIENCES, published by SPRINGER-VERLAG ITALIA SRL, is a premier journal that has been a cornerstone in the field of neurology and related disciplines since its inception in 1996. With an impressive Q1 ranking in Dermatology and Q2 rankings in Neuroloy (clinical) as well as Psychiatry and Mental Health, this journal consistently delivers high-quality peer-reviewed research that informs and shapes clinical practice. The journal boasts a significant presence on Scopus, positioned in the 89th percentile for Dermatology, 73rd for Psychiatry and Mental Health, and 72nd for Neurology (clinical), reflecting its influential contributions to medical knowledge. Open Access options are available, ensuring that this valuable research is accessible to a wider audience committed to advancing their understanding of neurological sciences. As it converges into future years (2024 and beyond), NEUROLOGICAL SCIENCES aims to continue foster collaboration and innovation amongst researchers, professionals, and students within the neurology and mental health domains, making it an indispensable resource for those dedicated to improving patient outcomes and advancing scholarly dialogue.
Neurodegenerative Diseases
Connecting researchers to combat neurodegenerative challenges.Neurodegenerative Diseases, published by KARGER, is a prominent academic journal dedicated to advancing the field of neurology and neuroscience. With an ISSN of 1660-2854 and E-ISSN 1660-2862, this journal serves as a vital platform for researchers, professionals, and students engaged in the exploration of neurodegenerative disorders from various perspectives, including clinical applications and therapeutic interventions. Spanning two decades since its inception in 2004 and set to converge in 2024, it has steadily built a reputation within the academic community, achieving a commendable Q2 ranking in clinical neurology and Q3 in general neurology according to the 2023 category quartiles. The journal boasts an impressive Scopus rank of 114/400 (71st percentile) in clinical neurology and 58/192 (70th percentile) in neuroscience neurology. While not classified as open access, the publication provides critical insights into the latest research and developments, making it an essential resource for anyone dedicated to understanding and combating neurodegenerative diseases.
LANCET NEUROLOGY
Exploring Breakthroughs in Neurological DisordersThe Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.
MOVEMENT DISORDERS
Unraveling the Complexities of Movement DisordersMOVEMENT DISORDERS, published by Wiley, stands as a premier outlet for cutting-edge research in the field of neurology, particularly focusing on the various aspects of movement disorders. With both its ISSN (0885-3185) and E-ISSN (1531-8257) identifiers, this journal is at the forefront of neurological research, holding a remarkable impact factor and recognized in the top quartiles (Q1) of the disciplines of Neurology and Clinical Neurology as of 2023. The journal boasts an impressive Scopus ranking, placing it in the top 8 out of 192 for Neuroscience-Neprology and 19 out of 400 for Medicine-Clinical Neurology, reflecting its high relevance and influence in the field. Released quarterly since its inception in 1986 and continuing through 2024, MOVEMENT DISORDERS publishes a mix of original research articles, reviews, and case reports that catalyze innovation and foster collaboration among researchers, healthcare professionals, and students dedicated to understanding and treating movement disorders. As a non-open access journal, it nevertheless offers valuable insights that are essential for the advancement of knowledge in neurology, making it a critical resource for anyone invested in this challenging and evolving field.
Journal of Clinical Neurology
Exploring the Frontiers of Neurological ResearchThe Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.
Revista Mexicana de Neurociencia
Exploring the Depths of Neuroscience in MexicoThe Revista Mexicana de Neurociencia, published by the ACAD MEXICANA NEUROLOGIA, serves as a pivotal platform for the dissemination of research within the field of neurology and neuroscience. Although it was active from 2008 to 2014 and is no longer covered in Scopus, the journal still holds a significant place in the academic community, addressing critical topics relevant to both clinical and experimental neurology. With an emphasis on advancing knowledge in neuropsychology and public health, this journal targets researchers, professionals, and students alike, fostering an interdisciplinary dialogue that can enhance the understanding of neurological conditions within Mexico and beyond. As it stands, the journal is not open access, which may present challenges for accessibility, yet its affiliation with recognized academic standards underlines its commitment to quality research. This platform once provided insights that can inform practice and stimulate innovative approaches in the management of neurological disorders, underscoring its importance in the evolving landscape of neuroscience.
ACTA NEUROLOGICA SCANDINAVICA
Innovating Understanding of Neurological DisordersACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.